The mandate, set to take effect just before Mayor Bill de Blasio leaves office, will apply to workers at about 184,000 businesses. It is likely to face legal challenges.
Source: New York Times
New York City to Mandate Vaccines for Employees at Private Businesses
Published in Adams, Eric L, Coronavirus (2019-nCoV), Coronavirus Omicron Variant, de Blasio, Bill and Vaccination and Immunization
More from Adams, Eric LMore posts in Adams, Eric L »
- Adams’s Re-election Bid Fueled by Real Estate Titans and Out-of-Towners
- Judge’s Rebuke of New York City Signals Potential of Rikers Takeover
- Six Charged With Organizing Illegal Donations to Adams’s 2021 Campaign
- Jordan Neely Was on New York’s ‘Top 50’ List of Homeless People at Risk
- Hochul and Adams Envision ‘New New York.’ Getting There Is the Trick.
More from Coronavirus (2019-nCoV)More posts in Coronavirus (2019-nCoV) »
More from Coronavirus Omicron VariantMore posts in Coronavirus Omicron Variant »
- New Covid Booster Shots Cut Risk of Hospitalization by Half, CDC Reports
- Will Covid Boosters Prevent Another Wave? Scientists Aren’t So Sure.
- Covid, Flu and RSV Are Increasing Hospitalizations in NYC
- Paxlovid Cuts Covid Deaths Among Older People, Israeli Study Finds
- Hochul says N.Y. students probably won’t have to mask, but keeps a public transit mandate.
More from de Blasio, BillMore posts in de Blasio, Bill »
- A Times Square Hotel Was Set To Become Affordable Housing. Then the Union Stepped In.
- As New York City Schools Face a Crisis, Charter Schools Gain Students
- Why New York Is Resorting to Tents to House Surge of Migrants
- A Horse’s Collapse Rekindles Debate about Carriage Rides in New York’s Central Park
- Why Rape Survivors Asked Feds to Probe N.Y.P.D.
More from Vaccination and ImmunizationMore posts in Vaccination and Immunization »
- New Covid Booster Shots Cut Risk of Hospitalization by Half, CDC Reports
- Will Covid Boosters Prevent Another Wave? Scientists Aren’t So Sure.
- Why It Was Easier to Curb Monkeypox Than Covid
- NYC Ends Monkeypox Emergency and Mobile Vaccine Vans
- Scientists Are Gaining On RSV, a Persistent Threat to Children
Be First to Comment